Vendor Collaboration - MULTI-CENTER CLINICAL TRIALS OF NOVEL THERAPIES FOR PATIENTS WITH WELL CHARACTERIZED GASTROPARESIS
NIDDK2017-0001
A RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) solicitation. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
See uploaded document for collaboration details
Comparable recent awards in RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
| Winner | Award value | Offers | Date |
|---|---|---|---|
| SOCIAL & SCIENTIFIC SYSTEMS, INC. | $11.2M | n/a | 2026-06-30 |
| SOCIAL & SCIENTIFIC SYSTEMS, INC. | $3.0M | n/a | 2026-06-30 |
| PPD DEVELOPMENT LP | $5.1M | 2 | 2026-06-26 |
| ASTRIX TECHNOLOGY LLC | $542K | 1 | 2026-06-08 |
| ASTRIX TECHNOLOGY LLC | $175K | 1 | 2026-06-03 |
Questions
What is solicitation NIDDK2017-0001?
Vendor Collaboration - MULTI-CENTER CLINICAL TRIALS OF NOVEL THERAPIES FOR PATIENTS WITH WELL CHARACTERIZED GASTROPARESIS, under NAICS 541712 (RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)).
What do similar contracts close for?
Comparable closed awards in this category ran from $175K to $11.2M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.